What is Adocia SA ADR?
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 170.44M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.